ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

22,733Medicare Part D Prescriptions Filled, Including Refills

Rank: 9 out of 1448

$918K Total Retail Price of All Prescriptions

Rank: 33 out of 1448

1,008 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
97% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

12% of this provider’s 1,008 patients filled at least one prescription for a schedule three drug, compared to an average of 2%.

Risky Drugs to Seniors

3% of this provider’s 19,710 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$40 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 12.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
SIMVASTATIN 1,588 1,361 1 3
OMEPRAZOLE 1,403 1,239 2 23
LOSARTAN POTASSIUM 918 779 3 11
FUROSEMIDE 878 762 4 7
METFORMIN HCL 869 729 5 25
BENAZEPRIL HCL 766 657 6 26
DIOVAN 712 659 7 15
AMLODIPINE BESYLATE 595 516 8 2
CARVEDILOL 580 498 9 1
METOPROLOL TARTRATE 567 498 10 9
ATENOLOL 513 465 11 12
GLIMEPIRIDE 497 441 12 66
WARFARIN SODIUM 470 377 13 8
GABAPENTIN 436 370 14 51
LEVOTHYROXINE SODIUM 422 362 15 21
HYDROCHLOROTHIAZIDE 401 359 16 18
DIGOXIN 386 325 17 13
LABETALOL HCL 361 320 18 100
NAPROXEN 345 293 19 112
HYDROCODONE-ACETAMINOPHEN 314 241 S3 20 33
ZOLPIDEM TARTRATE 307 260 21 34
TRAMADOL HCL 262 234 22 56
TAMSULOSIN HCL 259 216 23 46
LANTUS 250 229 24 111
JANUVIA 228 188 25 64
NITROSTAT 228 205 25 31
DIOVAN HCT 212 190 27 29
GLYBURIDE-METFORMIN HCL 194 191 R 28 132
GLYBURIDE 192 158 R 29 89
MECLIZINE HCL 190 171 30 108
INSULIN SYRINGE 179 136 31 139
ALLOPURINOL 175 157 32 43
CLOPIDOGREL 171 134 33 10
LOSARTAN-HYDROCHLOROTHIAZIDE 167 164 34 38
PLAVIX 164 139 35 14
TRIAMCINOLONE ACETONIDE 157 139 36 96
ACETAMINOPHEN-CODEINE 148 127 S3 37 113
ISOSORBIDE MONONITRATE ER 147 135 38 16
SPIRONOLACTONE-HCTZ 145 142 39 114
NAMENDA 140 136 40 93
PANTOPRAZOLE SODIUM 136 119 41 42
DILTIAZEM 24HR ER 134 105 42 52
NEXIUM 133 119 43 49
AMITRIPTYLINE HCL 133 107 R 43 153
AZITHROMYCIN 132 114 45 76
PREDNISONE 120 114 46 110
ALENDRONATE SODIUM 119 119 47 41
BENAZEPRIL-HYDROCHLOROTHIAZIDE 116 101 48 182
GLIPIZIDE 115 77 49 75
DEXILANT 115 103 49 87
POTASSIUM CHLORIDE 111 109 51 19
AMIODARONE HCL 104 91 52 22
NOVOLIN R 101 97 53 231
ATORVASTATIN CALCIUM 100 91 54 4
PROAIR HFA 94 88 55 104
SERTRALINE HCL 92 77 56 99
PRAVASTATIN SODIUM 89 74 57 20
METOCLOPRAMIDE HCL 88 78 58 190
FENOFIBRATE 85 80 59 54
ISOSORBIDE DINITRATE 82 82 60 63
CILOSTAZOL 79 78 61 95
HUMULIN R 78 66 62 254
ADVAIR DISKUS 76 60 63 74
CIPROFLOXACIN HCL 76 70 63 137
DONEPEZIL HCL 74 74 65 68
LISINOPRIL 73 52 66 5
MINOXIDIL 73 58 66 233
SPIRONOLACTONE 69 50 68 24
RANITIDINE HCL 67 54 69 109
CLOTRIMAZOLE-BETAMETHASONE 66 59 70 239
SURE COMFORT 64 56 71 240
LACTULOSE 63 56 72 184
DILTIAZEM 24HR CD 60 60 73 61
HYDROXYCHLOROQUINE SULFATE 60 56 73 371
MEGESTROL ACETATE 58 53 R 75 126
LOVASTATIN 55 46 76 35
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 27, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.